Literature DB >> 20360204

Calcification in a case of circumscribed myositis ossificans.

Maria Ibarra1, Pauline M Chou, Lauren M Pachman, Yong-Dong Zhao, Adele L Boskey.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20360204      PMCID： PMC3357497          DOI： 10.3899/jrheum.090833

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

Review 1.  Heterotopic ossification: a review.

Authors:  Luc Vanden Bossche; Guy Vanderstraeten
Journal:  J Rehabil Med       Date:  2005-05       Impact factor: 2.912

2.  Histologic, physical and chemical investigation of myositis ossificans traumatica.

Authors:  J Pintér; G Lénárt; G Rischák
Journal:  Acta Orthop Scand       Date:  1980-12

3.  Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation.

Authors:  Lauren M Pachman; Arthur Veis; Stuart Stock; Kathy Abbott; Frank Vicari; Pravin Patel; Diana Giczewski; Catherine Webb; Lyudmila Spevak; Adele L Boskey
Journal:  Arthritis Rheum       Date:  2006-10

Review 4.  Calcinosis in rheumatic diseases.

Authors:  Nina Boulman; Gleb Slobodin; Michael Rozenbaum; Itzhak Rosner
Journal:  Semin Arthritis Rheum       Date:  2005-06       Impact factor: 5.532
  4 in total
  3 in total

1.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

2.  Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome.

Authors:  C M Gordon; R H Cleveland; K Baltrusaitis; J Massaro; R B D'Agostino; M G Liang; B Snyder; M Walters; X Li; D T Braddock; M E Kleinman; M W Kieran; L B Gordon
Journal:  Bone       Date:  2019-05-08       Impact factor: 4.398

3.  A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.

Authors:  Sanne Treurniet; Elisabeth M W Eekhoff; Felix N Schmidt; Dimitra Micha; Björn Busse; Nathalie Bravenboer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.